Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Main Authors: | Chen, Leonard N, Suy, Simeng, Uhm, Sunghae, Oermann, Eric K, Ju, Andrew W, Chen, Viola, Hanscom, Heather N, Laing, Sarah, Kim, Joy S, Lei, Siyuan, Batipps, Gerald P, Kowalczyk, Keith, Bandi, Gaurav, Pahira, John, McGeagh, Kevin G, Collins, Brian T, Krishnan, Pranay, Dawson, Nancy A, Taylor, Kathryn L, Dritschilo, Anatoly, Lynch, John H, Collins, Sean P |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610192/ |
Similar Items
-
Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm3)
by: Janowski, Einsley, et al.
Published: (2014) -
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer
by: Oermann, Eric K, et al.
Published: (2011) -
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies
by: Chen, Leonard N, et al.
Published: (2014) -
Potency preservation following stereotactic body radiation therapy for prostate cancer
by: Obayomi-Davies, Olusola, et al.
Published: (2013) -
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
by: Ju, Andrew W, et al.
Published: (2013)